Annual Financial Report

Fidelity China Special Situations PLC reported NAV total return of +10.7% and share price total return of +9.5% for the year ended 31 March 2026, outperforming the MSCI China Index at +1.6%. The board recommended a final ordinary dividend of 9.00 pence per share, up 12.5% year over year. Performance was driven primarily by stock selection, especially in selected consumer discretionary holdings.

Analysis

The signal here is less about a single-year outperformance print and more about proof that active China exposure is becoming a stock-picking market rather than a beta market. That matters because the dispersion in earnings revisions is likely to stay wide: companies with pricing power, domestic demand leverage, and clean balance sheets can keep compounding even if index-level macro remains sluggish. The dividend raise also suggests the board is comfortable with cash generation, which typically reduces the discount rate investors apply to the vehicle itself.

The second-order effect is that winners in consumer discretionary and other idiosyncratic growth pockets may keep pulling liquidity away from passive China baskets and from lower-quality cyclicals. In practice, that should benefit high-conviction managers, local champions with share gains, and firms tied to premium consumption, while hurting exporters, commodity-sensitive names, and leverage-dependent laggards that need broad-based reflation to work. If the market starts rewarding quality cash returns, companies with weak capital allocation will face an even steeper valuation penalty.

The main risk is that this is a valuation rerating without confirmation from the macro tape. If policy stimulus fades, the renminbi weakens sharply, or external demand rolls over, the outperformance can compress quickly over a 1-3 month horizon as investors de-risk China again. The dividend narrative helps total return, but it also signals that the easy upside may be behind us if earnings growth does not broaden beyond a narrow set of winners.

The contrarian point is that consensus may still be underestimating the durability of alpha from domestic share shifts rather than headline GDP. If stock selection is now the dominant driver, then the opportunity set is less about owning China and more about owning the right subsector exposure within China. That supports a barbell: quality compounders on one side, and outright short exposure to structurally challenged businesses on the other.

Key Decisions for Investors

• Overweight active China-specialist exposure versus passive MSCI China proxies for the next 3-6 months; the return gap suggests index beta is not enough to capture dispersion.
• Long high-quality China consumer discretionary names with domestic revenue and net cash balance sheets; target a 10-15% relative outperformance over 2 quarters if revisions stay positive.
• Short structurally weak, leverage-heavy China cyclicals or exporters against the long book as a pair trade; best risk/reward if policy support remains uneven and alpha stays stock-specific.
• If available, buy 3-6 month call spreads on the Fidelity China Special Situations vehicle on pullbacks; the dividend increase reduces downside, while rerating upside is still plausible if sentiment improves.
• Reduce exposure to broad China beta after any sharp rally unless there is evidence of earnings breadth; use a 1-2 month review window because this trade can fade quickly if macro data deteriorates.